NeoChord announces completion of first-in-human case with NeXus TMVr technology
Ngày 06/10/2021 08:36 | Lượt xem: 613

NeoChord has announced successful completion of the first-in-human procedure with the NeoChord NeXuS transcatheter mitral chordal repair (TMVr) technology. The first-in-human procedure was performed at the University Hospital of Bordeaux, Bordeaux, France in collaboration with the Universitätsmedizin Mainz, Mainz, Germany. The patient treated has been discharged from the hospital and is back to a normal lifestyle.

 

“We are thrilled to announce this achievement,” said David Chung, president and chief executive officer of NeoChord. “On behalf of our entire organisation, I want to thank the collective team of physicians for bringing this first-in-human procedure to success. Coupled with our successful, clinical experience with the transapical device, this transcatheter milestone further establishes NeoChord as the leader for beating heart, off-pump mitral chordal repair, providing another tool for the Heart Teams to offer patients a surgically-proven technique with an interventional approach.”

“We are pleased with the positive result of this first-in-human procedure of the NeoChord NeXuS transcatheter mitral chordal repair device. The ability to replace a ruptured native chord by precisely placing suture in the mitral leaflet and securing with an anchor contributed to a very safe procedure,” said Thomas Modine, University Hospital of Bordeaux and Ralph Stephan von Bardeleben, Universitätsmedizin Mainz, who both co-led the procedure. “We integrated four decades of heart surgical experience into a venous transseptal intervention.”

“Chordal replacement was completed in textbook fashion,” said Azeem Latib, leading cardiologist from New York USA closely involved in the development of the NeoChord NeXuS transcatheter mitral chordal repair device and procedure. “Minimally invasive transcatheter chordal repair offers the promise of driving surgical-like results by maintaining the physiologic construction of the mitral valve, translating to better long-term outcomes.”

Mitral regurgitation (MR) is the most common heart valve disease, affecting millions of people worldwide. If left untreated, MR may lead to chronic heart failure.

The investigational NeoChord NeXuS transcatheter mitral chordal repair device is designed to restore function in patients with severe symptomatic primary MR, a disease where blood leaks backwards within the heart, due to ruptured native chords and the mitral valve’s inability to close properly.

The NeoChord NeXuS transcatheter mitral chordal repair device is unique from other mitral valve repair technologies in maintaining a natural physiologic functionality of the mitral valve. It is deployed through the vein using a transfemoral delivery catheter, navigated transeptally to the diseased native mitral valve. Due to minimal hardware used and the proven leaflet connection, NeoChord NeXuS preserves options for patients who may need re-intervention in the future.

Source CardiovascularNews

Duc Tin CLinic

Print Chia sẽ qua facebook bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua google bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua twitter bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua MySpace bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua LinkedIn bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua stumbleupon bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua icio bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua digg bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua yahoo bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua yahoo bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua yahoo bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology Chia sẽ qua yahoo bài: NeoChord announces completion of first-in-human case with NeXus TMVr technology

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP